Your session is about to expire
← Back to Search
LY3454738 (Reference Formulation) for Healthy Subjects
Study Summary
This trial will test the safety, dose, and effectiveness of a new drug and measure how long it stays in the body. It will last about 17 wks.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Is it possible for me to register for this clinical experiment?
"In order to be eligible for the trial, applicants must fall within 18-65 years of age and possess good general health. There are 30 slots available in total."
Are individuals currently being recruited to enroll in this research program?
"Per the data on clinicaltrials.gov, this particular medical trial is no longer recruiting patients for participation. Initially posted on September 1st 2024, it was last updated December 8th 2023. Although this study has ended recruitment efforts, there are 808 other trials that remain open to receiving candidates at present."
Is this research project admitting subjects who are over 30 years of age?
"This medical trial is open to adults aged 18 years or more, but younger than 65."
What potential risks should be considered prior to administering LY3454738 (Test Formulation)?
"As this is an early stage trial, only limited data exists about the safety and efficacy of LY3454738 (Test Formulation). This has led our team to rate its safety at 1 on a scale from one to three."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger